References
The GSTM1 and GSTT1 genetic polymorphisms and susceptibility to acute lymphoblastic leukemia in children from north Portugal Leukemia (2002) 16, 1565-1567. DOI: 10.1038/sj/leu/2402543 TO THE EDITOR Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer accounting for approximately 25-30% of all childhood malignancies. 1, 2 The origin of this disease can be explained by a combination of genetic and environmental factors, and therefore, like many other cancers, it is considered a complex disease, caused by the 'carcinogenetic' effect of the environment modified by a series of genes. Many of these genes tend to occur in allelic forms representing functional polymorphisms partially explaining inter-individual variability in cancer susceptibility. 1 However, chemical carcinogens are not reactive per se: they require metabolic activation before interacting with genetic material that may lead to mutations and eventually the initiation of cancer. The glutathione S-transferase mu-1 (GSTM1) and glutathione S-transferase theta-1 (GSTT1) are phase II enzymes that have the ability to detoxify numerous electrophilic compounds including the activated carcinogens.
1 Both GSTM1 and GSTT1 exhibit genetic polymorphism in populations with a large percentage of individuals displaying a homozygous deletion of the structural genes. Moreover, an increased frequency of GSTT1 and GSTM1 null genotypes (either in individual or combined status) has been associated with several malignancies.
Particularly concerning ALL, the studies until now performed besides being very scarce, have reported contradictory results for associations between GSTM1 and GSTT1 and cancer predisposition. For instance, Krajinovic et al 3 analyzing a case-control study that involved a white population of Canadians with French origin, reported a significant association between the presence of the GSTM1 null genotype and an increased risk of ALL. For GSTT1, the authors have not detected any apparent role in the etiology of ALL. However, in a previous study, Chen et al 2 have found that only the double null genotype for GSTM1 and GSTT1 was significantly more frequent among a sample of black children with ALL from USA, although failing to show a similar association among the white children analyzed. The discrepancies can be partially explained as the result of interpopulational differences in genetic backgrounds of susceptibility and/or of geographical differences in environmental exposure to carcinogens. 2, 3 Therefore, extensive population-specific studies are needed.
For studying in north Portugal the relationship between GSTM1 and GSTT1 genotypes and risk of susceptibility to ALL, we have applied the most recently described GSTM1 and GSTT1 genotyping procedures, which allow the unambiguous detection of the three genotypes that can result from deleted and non-deleted alleles. 4, 5 The detection of the deletions was PCR-based using the primers described by Kerb et al 4 and Sprenger et al 5 For both GSTM1 and GSTT1, the null alleles were co-amplified with the normal ones in a single reaction tube, and thereafter the amplified products were electrophoresed. For GSTT1, a 1460 bp fragment corresponded to the null allele and a fragment of 540 bp to the functional one ( Figure 1 ). For GSTM1, fragments of 8073 bp or 4748 bp indicated the presence of a functional allele or of a deleted allele, respectively (Figure 2) .
Patients enrolled in the study were 47 children with ALL, in various clinical phases, all undergoing the same chemotherapy protocol. As controls, 102 healthy subjects not following any therapeutic treatment and born in the same geographic area as patients, north Portugal, were analyzed.
Figure 1
Electrophoretic patterns of PCR-amplified GSTT1 fragments. Lanes 1, 2, 5 and 6, homozygous for the GSTT1 non-deleted allele; Lanes 4 and 8, heterozygous individuals; Lanes 3 and 7, homozygous for the GSTT1 null allele.
Figure 2
Electrophoretic patterns of PCR-amplified GSTM1 fragments. Lanes 4 and 9, homozygous for the GSTM1 non-deleted allele; Lanes 2, 3, 5, 6, 7 and 10, heterozygous individuals; Lanes 1, 8 and 11, homozygous for the GSTM1 null allele.
The frequencies of GSTM1 and GSTT1 genotypes in ALL patients and in control healthy individuals are presented in Table 1 . The genotypic distributions in all samples were found to be in Hardy-Weinberg equilibrium (ALL sample: P GSTT1 ϭ 0.56081, P GSTM1 ϭ 0.32979; control sample: P GSTT1 ϭ 0.43919, P GSTM1 ϭ 0.36276). Table 1 also gives the combined genotypic frequencies considering simultaneously GSTM1 and GSTT1.
Within the sample of healthy individuals from north Portugal, the observed frequencies of null homozygous for GSTT1 (25.5%) and GSTM1 (49%), fell into the range of values registered in other Caucasian populations, 15-30% for GSTT1 and 35-60% for GSTM1, and reflect the very high prevalence of the null genotypes observed at a world-wide scale. Since GSTs are involved in several detoxification processes and cellular detoxification is a major pathway of protection against chemical toxins and carcinogens, it has been claimed that all GSTs enzymes might have, perhaps, evolved to protect cells against reactive oxygen metabolites. 6 However, assuming this likely role, the widespread high prevalence of GSTM1 and GSTT1 deleted alleles is striking. This pattern of frequency distribution means, obviously, that GSTM1 and GSTT1 functional alleles are not mandatory, and further suggest that the null alleles were under condition of neutral selection within human populations, at least, in a recent evolutionary timeframe. We can admit, as Landi et al 6 that this apparent neutrality can be broken through time, as long as the effects of prolonged exposure to endogenous or exogenous genotoxicants, potentially resulting in cancer, are intensified. Supporting this view, seem to be the increased frequency of GSTM1 and GSTT1 null genotypes that has been consistently associated with several malignancies.
In this work, when the frequency of the three genotypic classes (++, +Ϫ and ϪϪ) for GSTT1 and GSTM1 were compared in ALL patients and healthy controls, no statistically significant differences between groups were detected (P ϭ0.09 for GSTM1 and P ϭ0.726 for GSTT1). However, it was worth noting the overrepresentation of GSTM1 null homozygous in the ALL sample (68.1%) in comparison to the registered in the control one (49%). In agreement with that finding, when the homozygous and heterozygous for the functional alleles were pooled, obtaining therefore only two classes for comparison, GSTT1/GSTM1 non-deleted alleles present (+Ϫ and ++) or absent (ϪϪ) as was considered in previous studies, based on methods that do not allow discrimination between homozygous and heterozygous, a statistically significant difference was found between patients and controls for the GSTM1 locus (P ϭ0.035; OR ϭ2.2; 95% Cl, 1.1-4.5). For GSTT1, differences were again not significant (P ϭ0.528). We have also analyzed the influence of the combined genotypes for GSTT1 and GSTM1, but no significant differences between the two samples were observed, nor considering two or three genotypic classes for each locus.
In summary, the results here obtained with a trial from north Portugal, point to the absence of any association between GSTT1 genotypes and susceptibility to childhood ALL. On the contrary, the GSTM1 null genotype was found to be correlated with an increased risk of developing the malignancy. Despite having not detected statistical differences between patients and controls when the three genotypic classes were compared, differences become evident when the comparative test was performed considering only the two phenotypic This could indicate that the full loss of GSTM1 activity must be the risk factor for ALL, whereas the presence of one functional allele in genotypes is enough to confer some protective function against the disease. Globally, these results are therefore in agreement with those obtained by Krajinovic et al. 3 Interestingly, also the data reported by Chen et al 2 for black and white American children, or by Lemos et al, 7 who have analyzed the GSTM1 genotypes in the context of ALL risk in Portugal working with a smaller sample from Coimbra (central region), revealed an identical trend for increased frequency of null genotypes among patients, albeit not obtaining levels of statistical difference comparatively to controls (see Table 2 , which summarizes the data published up to now).
Together, the consistent tendencies of independent data sets, suggest that GSTM1 might indeed be regarded as one predictive factor for childhood ALL, even if its prognostic value can vary from population to population.
Only further epidemiological studies and enlarged sized samples can provide a better understanding of the relationship between population-specific environmental variables and genetic backgrounds for this drug-metabolizing enzyme.
Finally, concerning the detection of a differential role of GSTM1 and GSTT1 in the etiology of childhood ALL, a possible explanation might be related with the pattern of tissue expression of the two enzymes. In white cell lineages GSTM1 is expressed whereas GSTT1 is not. 8 Therefore, the impact of inherited allelic variants such as deletions of GSTT1 and GSTM1, must be quite different in the genetic background that specifically predispose to ALL, and predictively minor for GSTT1, as the non-detection of associations between GSTT1 genotypes and ALL predisposition seems to lend support. 
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